[-] Show simple item record

dc.contributor.authorSchumann, Sarah-Anneen
dc.contributor.authorEwigman, Bernarden
dc.date.issued2007-11eng
dc.description.abstractWarfarin is as safe as aspirin and more effective for stroke prevention in elders with atrial fibrillation. Strength of recommendation (SOR) A: Well-designed randomized controlled trial of elderly patients in the primary care setting, consistent with findings from prior RCTs.en
dc.identifier.citationJournal of Family Practice, 56(11) 2007: 902-906.en
dc.identifier.urihttp://hdl.handle.net/10355/5406en
dc.publisherFamily Physicians Inquiries Networken
dc.relation.ispartofPriority Updates to Research Literature (PURLs)en
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network
dc.source.urihttp://data.memberclicks.com/site/fpin/61112007%20Warfarin%20and%20stroke.pdfen
dc.subjectcardiovascular preventionen
dc.subjecthemorrhage risken
dc.subjectanticoagulanten
dc.subject.lcshWarfarinen
dc.subject.lcshCerebrovascular disease -- Preventionen
dc.subject.lcshAspirin -- Therapeutic useen
dc.titleStroke prevention: Age alone does not rule out warfarinen
dc.typeArticleen


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record